Artemis Hospitals
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in India typically costs between AUD $13,433 and AUD $24,038. Total expenses depend on the extent of cancer resection required, the specific chemotherapy agents used, and the length of ICU stay. Australian patients can save approximately 81% compared to local private costs, which average AUD $96,859. Pricing usually includes the surgical procedure, anaesthetic, and the heated chemotherapy perfusion process.
Bookimed Expert Insight: Indian oncology centres offer high value for complex cases through specialised surgical expertise. Dr Raj Nagarkar, for example, has performed over 50,000 cancer surgeries. Clinics like Manipal Hospitals and Global Hospital Chennai hold JCI and NABH accreditations, ensuring quality standards. Some facilities also use advanced planning tools like IBM Watson for oncology to refine treatment protocols. This combination of vast clinical experience and international accreditation provides a reliable alternative for patients facing long Australian waitlists.
| India | Thailand | Turkey | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $13,433 | from AUD $42,420 | from AUD $31,815 |
No hidden fees – just official clinic prices. Pay at the clinic for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hyperthermic Intraperitoneal Chemotherapy (HIPEC) journey.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
The doctor is a highly skilled oncologist specializing in the treatment of various cancer types, including solid tumors, pediatric tumors, and hematological malignancies. She is proficient in both conservative and surgical treatments, such as the Whipple procedure.
She completed her MBBS at Lady Hardinge Medical College and MD in internal medicine from Maulana Azad Medical College. She further pursued DM Medical Oncology at Tata Memorial Hospital, where she also served as a consultant.
She is affiliated with international and national oncological societies and has expertise in lung, breast, gynecological, and genitourinary cancers, with a keen interest in immunotherapy and metronomic therapy.
The doctor received Surgical Oncology training at Tata Memorial Hospital, Mumbai, and completed MRCS at the Royal College of Surgeons, Edinburgh. Starting practice in 2000, the doctor founded Curie Manavata Cancer Centre in 2007. With 19 years of experience, the doctor has performed over 50,000 cancer surgeries and participated in more than 200 clinical trials. The doctor is a published author with numerous international and national publications. Specializing in Breast and Thoracic Surgical Oncology, the doctor is a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at MUHS.
The doctor completed an MD in Internal Medicine at Shyam Shah Medical College and held a Senior Residency in the same department. Following this, the doctor served as Registrar in Medical Oncology at Jawaharlal Nehru Cancer Hospital. The doctor completed DNB training in Medical Oncology at Indraprastha Apollo Hospital.
During the Senior Residency, the doctor lectured at the International Winter School of Oncology at AIIMS and presented research on Stomach Cancer at the Gastrointestinal Cancer Symposium by the American Society of Clinical Oncology. The doctor specializes in the molecular basis of cancer and targeted therapies.